These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 36070939)
1. The Postpartum Period Can Worsen Myelin Oligodendrocyte Glycoprotein Antibody-associated Encephalomyelitis. Yamamoto S; Yano M; Miyamoto Y; Hanaoka T; Nishida Y; Kawano Y Intern Med; 2023 Apr; 62(7):1063-1066. PubMed ID: 36070939 [TBL] [Abstract][Full Text] [Related]
2. Astrocytoma with myelin oligodendrocyte glycoprotein antibody associated encephalomyelitis: A case report. Zhong G; Zhang J; Liu X; Yang S; Gu H Medicine (Baltimore); 2022 Oct; 101(40):e31003. PubMed ID: 36221336 [TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum, treatment and outcome of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease in children: a tertiary care experience. Serin HM; Yilmaz S; Simsek E; Kanmaz S; Eraslan C; Aktan G; Tekgul H; Gokben S Acta Neurol Belg; 2021 Feb; 121(1):231-239. PubMed ID: 33231843 [TBL] [Abstract][Full Text] [Related]
4. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes. Duignan S; Wright S; Rossor T; Cazabon J; Gilmour K; Ciccarelli O; Wassmer E; Lim M; Hemingway C; Hacohen Y Dev Med Child Neurol; 2018 Sep; 60(9):958-962. PubMed ID: 29468668 [TBL] [Abstract][Full Text] [Related]
5. Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes. Waters P; Fadda G; Woodhall M; O'Mahony J; Brown RA; Castro DA; Longoni G; Irani SR; Sun B; Yeh EA; Marrie RA; Arnold DL; Banwell B; Bar-Or A; JAMA Neurol; 2020 Jan; 77(1):82-93. PubMed ID: 31545352 [TBL] [Abstract][Full Text] [Related]
6. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases. Baumann M; Hennes EM; Schanda K; Karenfort M; Kornek B; Seidl R; Diepold K; Lauffer H; Marquardt I; Strautmanis J; Syrbe S; Vieker S; Höftberger R; Reindl M; Rostásy K Mult Scler; 2016 Dec; 22(14):1821-1829. PubMed ID: 26869530 [TBL] [Abstract][Full Text] [Related]
7. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M; Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053 [TBL] [Abstract][Full Text] [Related]
9. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis. Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865 [TBL] [Abstract][Full Text] [Related]
10. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats. Matsumoto Y; Park IK; Hiraki K; Ohtani S; Kohyama K Immunology; 2009 Sep; 128(1 Suppl):e250-61. PubMed ID: 19175799 [TBL] [Abstract][Full Text] [Related]
11. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies. Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of a group of Japanese children with myelin-oligodendrocyte glycoprotein encephalomyelitis without preventive immunosuppressive therapy. Hino-Fukuyo N; Haginoya K; Takahashi T; Nakashima I; Fujihara K; Takai Y; Akasaka M; Kure S Brain Dev; 2019 Oct; 41(9):790-795. PubMed ID: 31281008 [TBL] [Abstract][Full Text] [Related]
18. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders? Di Pauli F; Berger T Front Immunol; 2018; 9():2753. PubMed ID: 30555462 [TBL] [Abstract][Full Text] [Related]
19. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J; Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303 [TBL] [Abstract][Full Text] [Related]
20. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). Linington C; Lassmann H J Neuroimmunol; 1987 Dec; 17(1):61-9. PubMed ID: 2445777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]